Do you want to read an article? Please log in or register.
Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
CoughPulmonary Fibrosis
The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial
Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT
doi: 10.1016/
Cough
Face Masks and Cough Etiquette Reduce the Cough Aerosol Concentration of Pseudomonas aeruginosa in People with Cystic Fibrosis
Am J Respir Crit Care Med.
Wood ME, Stockwell RE, Johnson GR, Ramsay KA, Sherrard LJ, Jabbour N, Ballard E, O'Rourke P, Kidd TJ, Wainwright CE, Knibbs LD, Sly PD, Morawska L, Bell SC
doi: 10.1164/
COPDPulmonary Fibrosis
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
Microbiome.
Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, Brutsche MH, von Mering C
doi: 10.1186/s40168-017-0234-1.
RECOMMENDED
Pulmonary Fibrosis
Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Cardot-Martin E, Guillou-Guillemette HL, Berre RL, Ramel S, Bihan JL, Grenet D, Farfour E, Troussier F, Urban T, Billard L, Pilorgé L, Minoui-Tran A, Payan C, Munck MR, Héry-Arnaud G, Vallet S
doi: 10.1016/j.jcf.2020.09.003.
RECOMMENDED
Pulmonary Fibrosis
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Kos R, Brinkman P, Neerincx AH, Paff T, Gerritsen MG, Lammers A, Kraneveld AD, Heijerman HGM, Janssens HM, Davies JC, Majoor CJ, Weersink EJ, Sterk PJ, Haarman EG, Bos LD, Maitland-van der Zee AH, Amsterdam Mucociliary Clearance Disease (AMCD) Research Group and the Amsterdam UMC Breath Research Group.
doi: 10.1016/j.jcf.2021.04.015
Pulmonary Fibrosis
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Pediatr Pulmonol.
Bruch BA, Singh SB, Ramsey LJ, Starner TD
doi: 10.1002/ppul.24024.
RECOMMENDED
Pulmonary Fibrosis
Identification of Mycobacterium porcinum in patients with cystic Fibrosis: Pathogen or contaminant?
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Paul GR, Leber A, Nemastil CJ, Novak KJ, Brady M, Stack-Simone S, Greninger AL, Antonara S
doi: 10.1016/j.jcf.2020.01.004.
COMMENTED
Inhaled mannitol for cystic fibrosis
Cochrane Database Syst Rev.
Nevitt SJ, Thornton J, Murray CS, Dwyer T
doi: 10.1002/14651858.
RECOMMENDED
Pulmonary Fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L
doi: 10.1016/j.jcf.2020.07.022.